- Home
- NVAX vs OMCL Comparison
NVAX vs OMCL Comparison
Compare NVAX & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- OMCL
- Stock Information
- Founded
- NVAX 1987
- OMCL 1992
- Country
- NVAX United States
- OMCL United States
- Employees
- NVAX N/A
- OMCL N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- OMCL Computer Manufacturing
- Sector
- NVAX Health Care
- OMCL Technology
- Exchange
- NVAX Nasdaq
- OMCL Nasdaq
- Market Cap
- NVAX 2.0B
- OMCL 2.0B
- IPO Year
- NVAX 1995
- OMCL 2001
- Fundamental
- Price
- NVAX $8.57
- OMCL $44.32
- Analyst Decision
- NVAX Buy
- OMCL Buy
- Analyst Count
- NVAX 6
- OMCL 6
- Target Price
- NVAX $17.83
- OMCL $52.00
- AVG Volume (30 Days)
- NVAX 3.3M
- OMCL 513.6K
- Earning Date
- NVAX 02-26-2025
- OMCL 02-06-2025
- Dividend Yield
- NVAX N/A
- OMCL N/A
- EPS Growth
- NVAX N/A
- OMCL N/A
- EPS
- NVAX N/A
- OMCL N/A
- Revenue
- NVAX $885,193,000.00
- OMCL $1,064,205,999.00
- Revenue This Year
- NVAX N/A
- OMCL N/A
- Revenue Next Year
- NVAX N/A
- OMCL $5.24
- P/E Ratio
- NVAX N/A
- OMCL N/A
- Revenue Growth
- NVAX N/A
- OMCL N/A
- 52 Week Low
- NVAX $3.53
- OMCL $25.12
- 52 Week High
- NVAX $23.86
- OMCL $55.75
- Technical
- Relative Strength Index (RSI)
- NVAX 48.28
- OMCL 46.46
- Support Level
- NVAX $7.62
- OMCL $42.80
- Resistance Level
- NVAX $8.67
- OMCL $44.69
- Average True Range (ATR)
- NVAX 0.46
- OMCL 1.47
- MACD
- NVAX -0.03
- OMCL -0.12
- Stochastic Oscillator
- NVAX 44.60
- OMCL 34.62
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States.